✦ LIBER ✦

101Basiliximab (Simulect®) reduces the rate and severity of acute rejection in adult liver transplant recipients

✍ Scribed by NEUHAUS, P; NASHAN, B; CLAVIEN, P; KITTUR, D; SALIZZONI, M; RIMOLA, A; ABEYWICKRAMA, K; ORTMANN, C; CHODOFF, L; HALL, M

Book ID: 122889711
Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 152 KB
Volume: 6
Category: Article
ISSN: 1527-6465
DOI: 10.1016/S1527-6465(05)80129-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

151Basiliximab (Simulect ®) is safe and

151Basiliximab (Simulect ®) is safe and well tolerated in adult liver transplantation and provides a low rate of acute rejection

✍ CALMUS, Y; SCHEELE, J; GONZALEZPINTOARRILLAGA, I; JAURRIELAMAS, E; KLAR, E; PAGE 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Low rate of acute rejection and cytomega

Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab

✍ I. Folkmane; J. Bicans; D. Amerika; S. Chapenko; M. Murovska; R. Rosentals 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Safety and efficacy of basiliximab for t

Safety and efficacy of basiliximab for the prevention of acute rejection in kidney transplant recipients

✍ M.H Shah; M.Z.M Bokhari; M.T.M Bokhari; A Farooq; S.M Yousaf 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Incidence and severity of acute allograf

Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon

✍ Jain, Ashokkumar ;Demetris, Anthony J. ;Manez, Rafael ;Tsamanadas, Athanassisos 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 195 KB 👁 1 views

Interferon alfa-2b (IFN-alpha) therapy has been shown to be effective in the treatment of viral hepatitis B (HBV) or viral hepatitis C (HCV) in patients who did not undergo transplantation. However, in allograft recipients, treatment with IFN-alpha often leads to allograft rejection. The aim of the

Incidence and Severity of Acute Cellular

Incidence and Severity of Acute Cellular Rejection in Recipients Undergoing Adult Living Donor or Deceased Donor Liver Transplantation

✍ A. Shaked; R. M. Ghobrial; R. M. Merion; T. H. Shearon; J. C. Emond; J. H. Fair; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Mycophenolate Mofetil Use Is Associated

Mycophenolate Mofetil Use Is Associated with Decreased Risk of Late Acute Rejection in Adult Liver Transplant Recipients

✍ R. H. Wiesner; B. J. Steffen; K. M. David; A. H. Chu; R. D. Gordon; J. R. Lake 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB